Longstanding claims that one of the reasons for high drug prices in the US is the actions of pharmacy benefit management (PBM ... funded by the pharma industry trade group PhRMA – found that ...
The potential applications of artificial intelligence (AI) in biopharmaceuticals appear wide-ranging and transformative.
The Wasatch U.S. Select Fund—Investor Class gained 0.24% but underperformed the benchmark Russell 3000® Growth Index, which ...
The Cosmetovigilance Training Course provides an in-depth look at global cosmetic safety regulations, covering EU, US, and international compliance requirements. This CPD-certified course teaches ...
In the latest episode of Health Law Diagnosed, host Bridgette Keller discusses the new Massachusetts Health Care Market ...
In today’s clinical trials, compared to those of the past, there is increasing complexity, greater data collection, and a ...
Net Product Sales $29.6 Million, Cash Flow from Operations of $11.5 MillionFull Year Net Product Sales $120.8Million, Rolvedon ...
The global propolis market was valued at US$ 754.08 million in 2024 and is projected to reach US$ 1,031.31 million by 2033, growing at a CAGR of 3.54% during the forecast period 2025–2033. This steady ...
The U.S. over the counter (OTC) drugs market was valued at US$ 41.93 billion in 2024 and is projected to reach a market valuation of US$ 69.65 billion by 2033, growing at a CAGR of 5.8% during the ...
Q4 2024 Earnings Conference Call March 13, 2025 8:00 AM ETCompany ParticipantsLaure Park - Senior Vice President ...
Money Digest on MSN4h
How Much The Highest Paid CEOs In The US Actually MakeThere is a huge disparity between average CEO pay and worker pay, but these CEOs exemplify the trend at a level previously ...
Net Product Sales $29.6 Million, Cash Flow from Operations of $11.5 Million Full Year Net Product Sales $120.8 Million, Rolvedon Sales Exceed $60.0 Million Full Year Cash Flow from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback